Basic Information
| ID | DRAMP21111 |
|---|
| Sequence | LRRAARWARRLLRR |
|---|
| Length | 14 |
|---|
| Name | ASA (Derived from SLZP) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal |
|---|
| Pathogen | [Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=3.15 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=6.25 μg/ml);##Fungi : Sporothrix schenckii(MIC=12.5 μg/ml), Trichophyton mentagrophytes(MIC=100 μg/ml), Aspergillus fumigatus(MIC=50 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=12.5 μg/ml) |
|---|
| Hemolytic Activity | [Ref.25069749] 3% hemolysis at 10 μg/ml , 5% hemolysis at 20 μg/ml , 7.5% hemolysis at 30 μg/ml , 10% hemolysis at 40 μg/ml , 12% hemolysis at 50 μg/ml , 13% hemolysis at 60 μg/ml , 15% hemolysis at 70 μg/ml , 19% hemolysis at 80 μg/ml against human red blood cells |
|---|
| Cytotoxicity | [Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 100%, 93.6%, 86.8%, 82.9%, 80% and 77.9% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM. |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Amidation |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 25069749 |
|---|
